Researchers
Kovač, Mirjana
Results 61-80 of 117
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2014 | The c20068t gene variant in the 3 ' end of the prothrombin gene is the risk factor for recurrent pregnancy loss | Pruner, Iva | Conference Paper | Mp. category will be shown later |
| 2014 | C0221: Genotype CYP2C19 Effects on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis![]() | Backović, Dušan | Conference Paper | Mp. category will be shown later |
| 2014 | TTR in Assessment of the Efficacy and Safety of Warfarin Therapy in Patients with Atrial Fibrillation | Maslac, Aleksandar R; Kovac, Mirjana K | Conference Paper | Mp. category will be shown later |
| 2014 | The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment | Kovač, Mirjana | Conference Paper | Mp. category will be shown later |
| 2013 | Risk factors for recurrence after the first venous thromboembolic event in women | Mitic, Gorana P; Kovac, Mirjana K | Conference Paper | Mp. category will be shown later |
| 2013 | Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy | Rakićević, Ljiljana | Article | 22M22 |
| 2013 | Clinical characteristics of the first thrombosis process among young women and those over 45 years | Kovač, Mirjana | Conference Paper | Mp. category will be shown later |
| 2013 | A novel prothrombin c.1787G gt A mutation in Serbian family with recurrent thromboembolism-another case of antithrombin resistance | Đorđević, Valentina | Conference Paper | Mp. category will be shown later |
| 2013 | Pharmacogenetic tests could be helpful in predicting of VKA maintenance dose in elderly patients at treatment initiation | Kovač, Mirjana | Article | 22M22 |
| 2013 | A novel prothrombin mutation in two families with prominent thrombophilia - the first cases of antithrombin resistance in a Caucasian population | Đorđević, Valentina | Contribution to periodical | 21aM21a |
| 2013 | Učestalost PAI-1 4G/5G genske varijante u srpskoj populaciji | Đorđević, Valentina | Article | 53M53 |
| 2013 | Relevance of age as a risk factor for recurrence after first venous thromboembolic event in women | Mitic, Gorana P; Kovac, Mirjana K | Conference Paper | Mp. category will be shown later |
| 2012 | Clinical manifestation in hereditary thrombophilias and managenemt of thrombosis, pregnancy and delivery | Elezović, Ivo; Antić, Darko | Conference Paper | Mp. category will be shown later |
| 2012 | Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin | Kovač, Mirjana | Article | 22M22 |
| 2012 | Are thrombophilia more multifactorial than we thought: report of mosaicism for FII G20210A and novel FII T20061C gene variants | Đorđević, Valentina | Contribution to periodical | 21aM21a |
| 2012 | Pharmacogenetic tests could be helpful in predicting of VKA maintenance dose in elderly patients at treatment initiation | Kovač, Mirjana | Conference Paper | Mp. category will be shown later |
| 2012 | Assessment of risk factors for venous thromboembolism in women with breast carcinoma | Kovac, Zeljko; Kovač, Mirjana | Conference Paper | Mp. category will be shown later |
| 2012 | C0157 Comparison of the incidence of treatment complications of low molecular weight heparin use during pregnancy in thrombophilic and non-thrombophilic women | Mitić, Gorana | Article | 21M21 |
| 2011 | Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C9*1/*3 genotypes | Kovač, Mirjana | Article | 22M22 |
| 2011 | Therapeutic versus prophylactic low molecular weight heparin regimen during pregnancy: the incidence of treatment complications | Mitic, Gorana P; Kovac, Mirjana K | Conference Paper | Mp. category will be shown later |
